2,3-diphosphoglycerate has been researched along with Liver Dysfunction in 2 studies
2,3-Diphosphoglycerate: A highly anionic organic phosphate which is present in human red blood cells at about the same molar ratio as hemoglobin. It binds to deoxyhemoglobin but not the oxygenated form, therefore diminishing the oxygen affinity of hemoglobin. This is essential in enabling hemoglobin to unload oxygen in tissue capillaries. It is also an intermediate in the conversion of 3-phosphoglycerate to 2-phosphoglycerate by phosphoglycerate mutase (EC 5.4.2.1). (From Stryer Biochemistry, 4th ed, p160; Enzyme Nomenclature, 1992, p508)
2,3-bisphosphoglyceric acid : A bisphosphoglyceric acid that is glyceric acid carrying two phospho substituents at positions 2 and 3.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The erythrocyte 2,3-diphosphoglycerate (2,3-DPG) was studied in patients with liver diseases, chronic obstructive pulmonary disease, and in normal subjects." | 7.67 | Erythrocyte 2,3-diphosphoglycerate in liver diseases. ( Amuro, Y; Fujioka, H; Hada, T; Higashino, K; Nabeshima, K; Nakano, T; Tamura, S, 1987) |
| "The level of 2,3-DPG in hepatocellular carcinoma and/or liver cirrhosis was higher than that in more hypoxic chronic obstructive pulmonary disease." | 5.27 | Erythrocyte 2,3-diphosphoglycerate in liver diseases. ( Amuro, Y; Fujioka, H; Hada, T; Higashino, K; Nabeshima, K; Nakano, T; Tamura, S, 1987) |
| "The erythrocyte 2,3-diphosphoglycerate (2,3-DPG) was studied in patients with liver diseases, chronic obstructive pulmonary disease, and in normal subjects." | 3.67 | Erythrocyte 2,3-diphosphoglycerate in liver diseases. ( Amuro, Y; Fujioka, H; Hada, T; Higashino, K; Nabeshima, K; Nakano, T; Tamura, S, 1987) |
| "The level of 2,3-DPG in hepatocellular carcinoma and/or liver cirrhosis was higher than that in more hypoxic chronic obstructive pulmonary disease." | 1.27 | Erythrocyte 2,3-diphosphoglycerate in liver diseases. ( Amuro, Y; Fujioka, H; Hada, T; Higashino, K; Nabeshima, K; Nakano, T; Tamura, S, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Prchal, JT | 1 |
| Pastore, YD | 1 |
| Nakano, T | 1 |
| Fujioka, H | 1 |
| Tamura, S | 1 |
| Amuro, Y | 1 |
| Nabeshima, K | 1 |
| Hada, T | 1 |
| Higashino, K | 1 |
1 review available for 2,3-diphosphoglycerate and Liver Dysfunction
| Article | Year |
|---|---|
Erythropoietin and erythropoiesis: polycythemias due to disruption of oxygen homeostasis.
Topics: 2,3-Diphosphoglycerate; Bisphosphoglycerate Mutase; Erythropoiesis; Erythropoietin; Gene Expression | 2004 |
1 other study available for 2,3-diphosphoglycerate and Liver Dysfunction
| Article | Year |
|---|---|
Erythrocyte 2,3-diphosphoglycerate in liver diseases.
Topics: 2,3-Diphosphoglycerate; Bile Acids and Salts; Carcinoma, Hepatocellular; Diphosphoglyceric Acids; Er | 1987 |